How the Supreme Court’s Decision in Amgen v. Sanofi Impacts Pharmaceutical Patents

By: Nafsika Karavida On May 18, 2023, the Supreme Court of the United States (the “Court” or “SCOTUS”) handed down its decision in Amgen Inc. v. Sanofi (“Amgen/Sanofi” or the “Amgen case”) [1] , a fairly notorious case among pharmaceutical companies and patent nerds.  Amgen/Sanofi is about the so-called enablement...

Read More